Prospera Financial Services Inc
Position in PLX — Protalix BioTherapeutics, Inc.
CIK 1541625
Dallas, TX
Position in PLX
as of Mar 31, 2026
· filed Apr 14, 2026
Position Value
$908,296
New position
Shares Held
418,570
first reported quarter
Ownership
0.520%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Prospera Financial Services Inc holds $8,455,010 across 19 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,113 | $2,564,620 | |
| 2 | PBYI |
Puma Biotechnology, Inc.
|
158,762 | $1,287,559 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,571 | $1,277,092 | |
| 4 | TGTX |
Tg Therapeutics, Inc.
|
12,625 | $693,617 | |
| 5 | VKTX |
Viking Therapeutics, Inc.
|
9,781 | $381,556 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
4,194 | $332,542 | |
| 7 | SRPT |
Sarepta Therapeutics, Inc.
|
17,042 | $306,244 | |
| 8 | SLS |
SELLAS Life Sciences Group, Inc.
|
18,119 | $267,436 |
All Filings in PLX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $908,296 | 418,570 | Shares | Sole | 2026-04-14 | |
| No filing history on record for this holder in this stock. | ||||||